Study on the efficacy of octreotide acetate for cancer-related bowel obstruction
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2616030
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Octreotide acetate of 300 ug/day is administered primarily as a continuous subcutaneous infusion using a continuous infusion pump. Dosage is fixed at 300 ug/day until Day 4. In patients extubated by Day 4, dosage is fixed at 300 ug/day until Day 7.
Primary outcome(s): Amelioration of abdominal symptoms (subjective parameters)
Study Design: Single arm Non-randomized
创建时间：
2006-10-15
